MedPath

AYUSH M3 for Pre-Hypertensio

Phase 2
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Registration Number
CTRI/2020/09/028121
Lead Sponsor
CCRAS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients of either sex aged 30-65 years.

Diagnosed patients of Pre hypertension as per 7th report of JNC

(120-139 of Hg SBP or 80-89 mm of Hg DBP)

Willing and able to participate for 3 months

Exclusion Criteria

Patients who have history of Cardiac Arrhythmia, Acute Coronary Syndrome, Myocardial Infarction, congestive cardiac failure ,Stroke or Severe Arrhythmia in the last 6 months.

Essential Hypertension / Secondary hypertension.

Patients with concurrent Hepatic Dysfunction (defined as AST and/or ALT > 2 times of the upper normal limit) or Renal Dysfunction (defined as S. creatinine > 1.2 mg/dl),uncontrolled Pulmonary Dysfunction (asthmatic and COPD patients) or major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Neurological disorders, Endocrinal disorders, etc.) or Known cases of malignancy

Uncontrolled Diabetes Mellitus(HbA1C >8)

Women who are planning for conception / pregnant or lactating.

H/o hypersensitivity to any of the trial drugs or their ingredients.

Patient taking participation in any other clinical trial.

Any other condition which the P.I. thinks may jeopardize the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath